Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-13

Clinical Trial Update: POCone-UBiT-IR300 Pediatric Comparison Study [Phase 4]

View source ↗

Summary

A Phase 4 pediatric comparison trial of POCone-UBiT-IR300 for Helicobacter pylori infection completed, with results posted in January 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POCone-UBiT-IR300

Snippet

Sponsor: Otsuka America Pharmaceutical | Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori) | Phase 4 | Status: COMPLETED | Results posted: 2015-01-13